Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases
Nina Sonne, M.A. Karsdal, Kim Henriksen
Molecular Metabolism (2020) Vol. 46, pp. 101109-101109
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Future targets for migraine treatment beyond CGRP
Linda Al‐Hassany, Deirdre M. Boucherie, Hannah Creeney, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 29
Recent advances in peptide-based therapies for obesity and type 2 diabetes
Clifford J. Bailey, Peter R. Flatt, J. Michael Conlon
Peptides (2024) Vol. 173, pp. 171149-171149
Open Access | Times Cited: 11
Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
Wenfang Sun, Yali Li, Binbin Xia, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 11
New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists
Ferenc Sztanek, László Imre Tóth, Attila Pető, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1320-1320
Open Access | Times Cited: 11
Influence of metabolic state and body composition on the action of pharmacological treatment of migraine
Noor Bruijn, Romy van Lohuizen, Malgorzata Boron, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 9
Development of a Novel Assay for Direct Assessment of Selective Amylin Receptor Activation Reveals Novel Differences in Behavior of Selective and Nonselective Peptide Agonists
Peter Keov, George Christopoulos, Caroline A. Hick, et al.
Molecular Pharmacology (2024) Vol. 105, Iss. 5, pp. 359-373
Open Access | Times Cited: 5
Structural Analysis of Amylin and Amyloid β Peptide Signaling in Alzheimer’s Disease
Lisi Xie, Christopher Lockhart, Steven R. Bowers, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 89-89
Open Access
The protective effect of amylin in type 2 diabetes: Yes or no
Mohammad Saud Alanazi, Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.
European Journal of Pharmacology (2025), pp. 177593-177593
Open Access
Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors
Jianjun Cao, Matthew J. Belousoff, Rachel M. Johnson, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
The Goldilocks for chronic weight management—Balancing quantity with quality of weight loss
Kim Henriksen, Manu V. Chakravarthy, Cecilie Liv Bager, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Future directions in obesity pharmacotherapy
Nick Finer
European Journal of Internal Medicine (2021) Vol. 93, pp. 13-20
Closed Access | Times Cited: 24
Serum CGRP in migraine patients using erenumab as preventive treatment
Simone de Vries Lentsch, Ingrid M. Garrelds, A.H. Jan Danser, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Cryo-EM Structure of the Human Amylin 1 Receptor in Complex with CGRP and Gs Protein
Jianjun Cao, Matthew J. Belousoff, Radostin Danev, et al.
Biochemistry (2024) Vol. 63, Iss. 9, pp. 1089-1096
Open Access | Times Cited: 2
A Review of Calcitonin Gene-Related Peptide and Its Implications for Vestibular Disorders
R L Baron, Kristen K. Steenerson
Current Treatment Options in Neurology (2024) Vol. 26, Iss. 6, pp. 203-228
Closed Access | Times Cited: 2
The enduring metabolic improvement of combining dual amylin and calcitonin receptor agonist and semaglutide treatments in a rat model of obesity and diabetes
Anna Thorsø Larsen, Khaled Elhady Mohamed, Simone Anna Melander, et al.
AJP Endocrinology and Metabolism (2024) Vol. 327, Iss. 2, pp. E145-E154
Closed Access | Times Cited: 2
NN1213 – A Potent, Long-Acting, and Selective Analog of Human Amylin
Kirsten Dahl, Kirsten Raun, Jakob Lerche Hansen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11688-11700
Open Access | Times Cited: 2
Chronic salmon calcitonin exerts an antidepressant effect via modulating the p38 MAPK signaling pathway
Zhu Wenhui, Weifen Li, Jian Jiang, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 5
Is polypharmacy the future for pharmacological management of obesity?
Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin
Current Opinion in Endocrine and Metabolic Research (2022) Vol. 23, pp. 100322-100322
Open Access | Times Cited: 7
Salmon Calcitonin Exerts an Antidepressant Effect by Activating Amylin Receptors
Jian Jiang, Jun Ju, Liang Luo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Targeting appetite and satiety in diabetes and obesity, via G protein-coupled receptors
Noah B.C. Piper, Emily A. Whitfield, Gregory D. Stewart, et al.
Biochemical Pharmacology (2022) Vol. 202, pp. 115115-115115
Closed Access | Times Cited: 7
Development of High Affinity Calcitonin Analog Fragments Targeting Extracellular Domains of Calcitonin Family Receptors
Sang Min Lee
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1364-1364
Open Access | Times Cited: 8
Current and future approaches for in vitro hit discovery in diabetes mellitus
Xin Zhang, Erwin Kupczyk, Philippe Schmitt‐Kopplin, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103331-103331
Open Access | Times Cited: 5
Metabolic Homeostasis: It’s All in the Timing
Patricia L. Brubaker, Alexandre Martchenko
Endocrinology (2021) Vol. 163, Iss. 1
Open Access | Times Cited: 7
The Alteration in Parathyroid Hormone and Calcitonin of Pregnant Women in Babylon Governorate
Hossam Hammadi, Abdulsamie H. Alta’ee, Ban Musa
Journal of Biomedicine and Biochemistry (2023)
Open Access | Times Cited: 2
Utility of an experimental medicine model to evaluate efficacy, side-effects and mechanism of action of novel treatments for obesity and binge-eating disorder
Elizabeth M. Schneider, Colin T. Dourish, Suzanne Higgs
Appetite (2022) Vol. 176, pp. 106087-106087
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top